Biosynthesis specialist and Narcan ingredient maker Antheia reels in $56M in series C funding
4th June 2025 Uncategorised 0Antheia, a biomanufacturer that makes a key ingredient for the opioid overdose treatment Narcan, reeled in $56 million in series C financing it said will be used to expand manufacturing operations in the U.S. and to start new programs in Singapore.
More: Biosynthesis specialist and Narcan ingredient maker Antheia reels in M in series C funding
Source: fierce